4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-26-009203
SrVP/CFO/Prin Fin & Acct Ofcr bought 5,700 shares at $0.89 ($5,073)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 2026-01-30 | Purchase | +5,700 | $0.89 | $5,073 | 33,433 | D |
| Derivatives | |||||||
| Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 2026-01-30 | Purchase · Common Warrant | +5,700 | 5,700 | D | ||
| Open-market purchases · 5,700 sh · avg $0.89 · $5,073 | |||||||
Loading xslF345X05/tm264801-1_4seq1.xml…